The association between endometriosis and risk of endometrial cancer and breast cancer: a meta-analysis
Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differen...
Saved in:
Published in | BMC women's health Vol. 22; no. 1; pp. 455 - 21 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
18.11.2022
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1472-6874 1472-6874 |
DOI | 10.1186/s12905-022-02028-x |
Cover
Loading…
Abstract | Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis.
We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I
were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias.
Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)].
Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. |
---|---|
AbstractList | Abstract Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle–Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg’s and Egger’s tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case–control studies. Data from large cohort and case–control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148–2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001–1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I.sup.2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis.PURPOSEEndometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis.We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias.METHODSWe searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias.Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)].RESULTSOf the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)].Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management.CONCLUSIONEndometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle-Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I.sup.2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg's and Egger's tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case-control studies. Data from large cohort and case-control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148-2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001-1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. Keywords: Endometriosis, Endometrial cancer, Breast cancer, Risk, Meta-analysis Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer. Epidemiological and biological data on endometriosis might explain links between endometriosis and these cancers. We sought to identify the differences in the risk of endometrial cancer and breast cancer between women with and women without endometriosis. Methods We searched PubMed, EMBASE, the Cochrane Library, and four Chinese databases (CNKI, VIP, WanFang, CBM) to identify relevant studies published online between January 2011 and March 2021. In our meta-analysis, we used the Newcastle–Ottawa Scale (NOS) to evaluate the design and quality of all studies, and we calculated the pooled risk ratio (RR) using the random model. The Q test and I2 were used to evaluate the degree of heterogeneity of eligible studies. We used funnel plots and Begg’s and Egger’s tests to assess publication bias. Results Of the 1369 articles, we finally included 14 cohort studies and seven case–control studies. Data from large cohort and case–control studies indicate that women with endometriosis had an increased risk of both endometrial cancer [RR, 1.662; 95% CI, (1.148–2.407)] and breast cancer [RR, 1.082; 95% CI, (1.001–1.169)]. Conclusion Endometriosis can increase the risk of endometrial cancer and breast cancer, and women with endometriosis are recommended to receive routine screening in long-term management. |
ArticleNumber | 455 |
Audience | Academic |
Author | Huang, Xia Peng, Hongling Qi, Xiaorong Ye, Jiatian |
Author_xml | – sequence: 1 givenname: Jiatian orcidid: 0000-0002-0419-3984 surname: Ye fullname: Ye, Jiatian – sequence: 2 givenname: Hongling surname: Peng fullname: Peng, Hongling – sequence: 3 givenname: Xia surname: Huang fullname: Huang, Xia – sequence: 4 givenname: Xiaorong orcidid: 0000-0002-8382-9433 surname: Qi fullname: Qi, Xiaorong |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36401252$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1v1DAQhiNURD_gD3BAkbhwSbGdxB8ckKqKj0qVuJSzNXbGWy9Zu9hZaP893uzSdiuEoijRzDNPMtZ7XB2EGLCqXlNySqnk7zNlivQNYazchMnm9ll1RDvBGi5Fd_Do_bA6znlJCBWyFy-qw5Z3hLKeHVWLq2usIedoPUw-htrg9Bsx1BiGuMIp-Zh9riEMdfL5Rx3dQwfG2kKwmOa2SQh52lU-1FAXBhoIMN4Vw8vquYMx46vd86T6_vnT1fnX5vLbl4vzs8vG9rydGiY4OMV7FEZ1TgzcIfatlEAscEGkUYpbDsKaDoziTlFhWyHLMtwqa1x7Ul1svUOEpb5JfgXpTkfwei7EtNCQJm9H1Nih4QNlA1rRuZbKwUjDeQeDowoELa6PW9fN2qxwsBimBOOedL8T_LVexF9acdG2pC2CdztBij_XmCe98tniOELAuM6aiVZSxZiSBX37BF3GdSqHN1OCM84pf6AWUBbwwcXyXbuR6jPByvkw2m9cp_-gyjXgytuSIedLfW_gzeNF7zf8G5MCsC1gU8w5obtHKNGbLOptFnXJop6zqG_LkHwyZP00h6z8jh__N_oHFUjjpQ |
CitedBy_id | crossref_primary_10_3390_biom13061003 crossref_primary_10_1136_ijgc_2023_005132 crossref_primary_10_1186_s43043_025_00219_8 crossref_primary_10_37349_etat_2023_00176 crossref_primary_10_1016_j_jeud_2023_100040 crossref_primary_10_1016_j_sciaf_2023_e01833 crossref_primary_10_5468_ogs_24242 crossref_primary_10_1016_j_jri_2025_104449 crossref_primary_10_3390_cancers15235667 crossref_primary_10_3390_curroncol31010032 crossref_primary_10_3390_futurepharmacol2040039 crossref_primary_10_31083_j_ceog5107169 crossref_primary_10_3390_cells14030156 crossref_primary_10_3390_biology13060397 crossref_primary_10_1002_hsr2_1274 crossref_primary_10_3390_clinpract14010001 crossref_primary_10_3390_biomedicines11030978 crossref_primary_10_21518_ms2024_497 crossref_primary_10_1016_j_ijgc_2025_101681 crossref_primary_10_1177_22840265241283520 crossref_primary_10_1038_s41598_024_58950_7 crossref_primary_10_1093_humrep_deae053 crossref_primary_10_1002_ijgo_15509 crossref_primary_10_1016_j_ejphar_2024_177031 crossref_primary_10_1016_j_heliyon_2024_e38130 crossref_primary_10_3390_medicina60081341 crossref_primary_10_3389_fonc_2023_1274340 crossref_primary_10_1158_1055_9965_EPI_23_1014 crossref_primary_10_3390_ijms25126775 crossref_primary_10_3390_biomedicines12122801 crossref_primary_10_1016_j_cjco_2023_11_003 crossref_primary_10_1002_wsbm_1624 crossref_primary_10_1007_s10549_023_07211_8 crossref_primary_10_1158_1078_0432_CCR_24_1205 crossref_primary_10_1186_s12940_023_01034_2 crossref_primary_10_1007_s12013_024_01420_8 crossref_primary_10_1016_j_isci_2024_109680 crossref_primary_10_3346_jkms_2024_39_e284 |
Cites_doi | 10.7717/peerj.8135 10.1016/j.critrevonc.2018.12.009 10.1097/igc.0000000000000075 10.3390/ijms20153822 10.1093/humupd/dmaa045 10.1016/j.ygyno.2011.08.022 10.28991/HEF-2021-02-04-01 10.1097/01.ogx.0000529864.64356.76 10.1210/er.2012-1043 10.1016/j.mce.2013.07.026 10.3390/ijerph16183469 10.3390/ijms14035367 10.1016/j.critrevonc.2019.03.001 10.1200/jco.2013.48.9021 10.1016/j.jegh.2013.08.003 10.1016/j.ygyno.2016.07.095 10.28991/SciMedJ-2021-0302-8 10.1093/annonc/mdv484 10.1371/journal.pone.0194011 10.18632/oncotarget.19246 10.3389/frph.2021.661360 10.1038/bjc.2014.29 10.1186/s12885-015-1821-9 10.1007/s10549-014-3252-8 10.5301/jbm.2008.5555 10.1007/s00404-018-4968-1 10.1007/s00404-015-3809-8 10.9777/mcb.2013.10005 10.2174/1573406413666170424155452 10.1093/aje/kwq510 10.1016/j.freeradbiomed.2018.12.015 10.1080/13697137.2021.1948994 10.3390/cells10061381 10.3390/ijms22105196 10.1097/IGC.0000000000000384 10.1080/09513590.2020.1855634 10.1136/bmj.k2644 10.1016/j.ygyno.2021.01.019 10.1007/s10654-018-0474-9 10.1210/endrev/bnz001 10.1530/JME-15-0310 10.1007/s12325-020-01363-5 10.3760/cma.j.issn.0529-567x.2018.12.007 10.1186/s13048-019-0503-7 10.1097/AOG.0000000000001684 10.1089/jwh.2017.6432 10.3389/fgene.2021.631715 10.1016/j.bpobgyn.2018.06.001 10.3390/ijerph13111138 10.1097/IGC.0000000000000454 10.1016/j.gofs.2018.02.017 10.1016/j.cell.2021.04.041 10.17116/kurort20199606132 10.1002/ijc.31721 10.7150/jca.39626 10.1371/journal.pone.0143410 10.1186/s12905-019-0770-x 10.1177/1533034616666644 10.1038/s41572-018-0008-5 10.1007/s10552-014-0510-3 10.1158/1055-9965.EPI-13-0996 10.1007/s10552-017-0856-4 10.28991/SciMedJ-2021-0303-3 10.1136/bmj.327.7414.557 |
ContentType | Journal Article |
Copyright | 2022. The Author(s). COPYRIGHT 2022 BioMed Central Ltd. 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022 |
Copyright_xml | – notice: 2022. The Author(s). – notice: COPYRIGHT 2022 BioMed Central Ltd. – notice: 2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7R6 7RV 7X7 7XB 888 88E 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PIMPY PJZUB PKEHL PMKZF PPXIY PQEST PQGEN PQQKQ PQUKI PSYQQ QXPDG 7X8 5PM DOA |
DOI | 10.1186/s12905-022-02028-x |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) GenderWatch Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) GenderWatch (Alumni Edition) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest Digital Collections ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Women's Studies ProQuest One Academic ProQuest One Academic UKI Edition ProQuest One Psychology Diversity Collection MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Psychology ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest One Sustainability Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Diversity Collection ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) GenderWatch (Alumni Edition) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Digital Collections Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library GenderWatch ProQuest One Academic UKI Edition ProQuest Women's & Gender Studies ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (WRLC) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Public Health |
EISSN | 1472-6874 |
EndPage | 21 |
ExternalDocumentID | oai_doaj_org_article_e4eb6d12dec74f318db8b664adf19a71 PMC9673303 A727082158 36401252 10_1186_s12905_022_02028_x |
Genre | Meta-Analysis Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 04C 0R~ 23N 2WC 53G 5VS 6J9 6PF 7R6 7RV 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACHQT ACIHN ACUHS ADBBV ADOJX ADRAZ ADUKV AEAQA AENEX AEUYN AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BKEYQ BMC BMSDO BPHCQ BVXVI C6C CCPQU CITATION DIK DU5 E3Z EBD EBLON EBS ECF ECT EIHBH ESX EX3 F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICW IHR INH INR ITC KQ8 M1P M48 M~E NAPCQ O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PMKZF PQQKQ PROAC PSQYO PSYQQ QXPDG RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M CGR CUY CVF ECM EIF NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PJZUB PKEHL PPXIY PQEST PQGEN PQUKI 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c563t-276af965e7b94f7d6fee5388a0ca6708b996c6a7cb4ab96f917c3780126c9cbf3 |
IEDL.DBID | M48 |
ISSN | 1472-6874 |
IngestDate | Wed Aug 27 01:25:51 EDT 2025 Thu Aug 21 18:39:54 EDT 2025 Tue Aug 05 10:14:13 EDT 2025 Sat Jul 26 03:31:33 EDT 2025 Tue Jun 17 21:31:18 EDT 2025 Tue Jun 10 20:54:29 EDT 2025 Thu Apr 03 07:03:31 EDT 2025 Tue Jul 01 00:26:24 EDT 2025 Thu Apr 24 23:02:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Endometriosis Risk Breast cancer Endometrial cancer Meta-analysis |
Language | English |
License | 2022. The Author(s). Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c563t-276af965e7b94f7d6fee5388a0ca6708b996c6a7cb4ab96f917c3780126c9cbf3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Feature-1 content type line 23 |
ORCID | 0000-0002-8382-9433 0000-0002-0419-3984 |
OpenAccessLink | https://www.proquest.com/docview/2737626616?pq-origsite=%requestingapplication% |
PMID | 36401252 |
PQID | 2737626616 |
PQPubID | 42554 |
PageCount | 21 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e4eb6d12dec74f318db8b664adf19a71 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9673303 proquest_miscellaneous_2738192298 proquest_journals_2737626616 gale_infotracmisc_A727082158 gale_infotracacademiconefile_A727082158 pubmed_primary_36401252 crossref_primary_10_1186_s12905_022_02028_x crossref_citationtrail_10_1186_s12905_022_02028_x |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2022-11-18 |
PublicationDateYYYYMMDD | 2022-11-18 |
PublicationDate_xml | – month: 11 year: 2022 text: 2022-11-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC women's health |
PublicationTitleAlternate | BMC Womens Health |
PublicationYear | 2022 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | FE Lundberg (2028_CR32) 2019; 34 CL Williams (2028_CR25) 2018; 362 D Barca (2028_CR9) 2021; 2 L Del Pup (2028_CR65) 2019; 137 IJ Rowlands (2028_CR40) 2011; 123 L Saavalainen (2028_CR31) 2018; 143 PTK Saunders (2028_CR3) 2021; 184 J Bian (2028_CR53) 2017; 16 LA Brinton (2028_CR30) 2014; 23 2028_CR37 LV Shchegolikhina (2028_CR10) 2019; 96 2028_CR35 VC Kok (2028_CR29) 2015; 25 TL Rižner (2028_CR59) 2013; 381 A Nazmeen (2028_CR51) 2017; 13 JJ Kim (2028_CR55) 2013; 34 L Saraswat (2028_CR22) 2018; 73 G Schultes (2028_CR48) 1999; 149 L Huzell (2028_CR66) 2015; 149 HC Yu (2028_CR33) 2015; 25 2028_CR63 M Kvaskoff (2028_CR16) 2021; 27 V Dochez (2028_CR50) 2019; 12 SB Bhyan (2028_CR12) 2019; 7 JP Higgins (2028_CR28) 2003; 327 F Shen (2028_CR39) 2020; 11 F Guidozzi (2028_CR15) 2021; 24 2028_CR23 2028_CR20 AT Ali (2028_CR61) 2014; 24 C Fang (2028_CR52) 2017; 8 SK Bardaweel (2028_CR64) 2019; 19 A Maiorana (2028_CR49) 2007; 22 2028_CR19 2028_CR18 GA Wells (2028_CR27) 2014 J Li (2028_CR13) 2019; 299 S Gandini (2028_CR26) 2019; 134 ML Cote (2028_CR60) 2015; 26 LR Alvaro (2028_CR45) 2021; 3 O Olabode Ebenezer (2028_CR46) 2021; 3 2028_CR2 PG Moorman (2028_CR62) 2013; 31 2028_CR4 H Zhao (2028_CR58) 2016; 57 2028_CR7 N Colombo (2028_CR44) 2016; 27 2028_CR6 L Morales (2028_CR24) 2013; 3 B Borghese (2028_CR1) 2018; 46 HB Nichols (2028_CR38) 2011; 173 2028_CR11 H Kajiyama (2028_CR14) 2019; 133 Q Zhong (2028_CR47) 2021; 12 N Pedachenko (2028_CR57) 2021; 37 LM Mikhaleva (2028_CR8) 2020; 37 KT Zondervan (2028_CR5) 2018; 4 ES Surrey (2028_CR21) 2018; 27 2028_CR41 EM Poole (2028_CR36) 2017; 28 CC Yeh (2028_CR34) 2018; 13 F Anifantaki (2028_CR56) 2016; 293 HS Kim (2028_CR17) 2014; 110 MJ Worley (2028_CR54) 2013; 14 2028_CR43 2028_CR42 |
References_xml | – volume: 7 start-page: e8135 year: 2019 ident: 2028_CR12 publication-title: PeerJ doi: 10.7717/peerj.8135 – volume: 134 start-page: 72 year: 2019 ident: 2028_CR26 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2018.12.009 – volume: 24 start-page: 384 year: 2014 ident: 2028_CR61 publication-title: Int J Gynecol Cancer doi: 10.1097/igc.0000000000000075 – ident: 2028_CR63 doi: 10.3390/ijms20153822 – volume: 27 start-page: 393 year: 2021 ident: 2028_CR16 publication-title: Hum Reprod Update doi: 10.1093/humupd/dmaa045 – volume: 123 start-page: 537 year: 2011 ident: 2028_CR40 publication-title: Gynecol Oncol doi: 10.1016/j.ygyno.2011.08.022 – volume: 2 start-page: 323 year: 2021 ident: 2028_CR9 publication-title: J Human Earth Future doi: 10.28991/HEF-2021-02-04-01 – volume: 73 start-page: 92 year: 2018 ident: 2028_CR22 publication-title: Obstet Gynecol Survey doi: 10.1097/01.ogx.0000529864.64356.76 – volume: 34 start-page: 130 year: 2013 ident: 2028_CR55 publication-title: Endocr Rev doi: 10.1210/er.2012-1043 – volume: 381 start-page: 124 year: 2013 ident: 2028_CR59 publication-title: Mol Cellular Endocrinol doi: 10.1016/j.mce.2013.07.026 – ident: 2028_CR37 doi: 10.3390/ijerph16183469 – volume: 14 start-page: 5367 year: 2013 ident: 2028_CR54 publication-title: Int J Mol Sci doi: 10.3390/ijms14035367 – volume: 137 start-page: 123 year: 2019 ident: 2028_CR65 publication-title: Crit Rev Oncol Hematol doi: 10.1016/j.critrevonc.2019.03.001 – volume: 31 start-page: 4188 year: 2013 ident: 2028_CR62 publication-title: J Clin Oncol doi: 10.1200/jco.2013.48.9021 – volume: 3 start-page: 205 year: 2013 ident: 2028_CR24 publication-title: J Epidemiol Global Health doi: 10.1016/j.jegh.2013.08.003 – ident: 2028_CR20 doi: 10.1016/j.ygyno.2016.07.095 – volume: 3 start-page: 166 year: 2021 ident: 2028_CR45 publication-title: SciMedicine J doi: 10.28991/SciMedJ-2021-0302-8 – volume: 27 start-page: 16 year: 2016 ident: 2028_CR44 publication-title: Ann Oncol doi: 10.1093/annonc/mdv484 – volume: 13 start-page: e0194011 year: 2018 ident: 2028_CR34 publication-title: PLoS One doi: 10.1371/journal.pone.0194011 – volume: 8 start-page: 63963 year: 2017 ident: 2028_CR52 publication-title: Oncotarget doi: 10.18632/oncotarget.19246 – ident: 2028_CR6 doi: 10.3389/frph.2021.661360 – volume: 110 start-page: 1878 year: 2014 ident: 2028_CR17 publication-title: Br J Cancer doi: 10.1038/bjc.2014.29 – ident: 2028_CR42 doi: 10.1186/s12885-015-1821-9 – volume: 149 start-page: 505 year: 2015 ident: 2028_CR66 publication-title: Breast Cancer Res Treatment doi: 10.1007/s10549-014-3252-8 – volume: 22 start-page: 200 year: 2007 ident: 2028_CR49 publication-title: Int J Biol Markers doi: 10.5301/jbm.2008.5555 – volume: 299 start-page: 35 year: 2019 ident: 2028_CR13 publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-018-4968-1 – volume: 293 start-page: 5 year: 2016 ident: 2028_CR56 publication-title: Arch Gynecol Obstet doi: 10.1007/s00404-015-3809-8 – ident: 2028_CR23 doi: 10.9777/mcb.2013.10005 – volume-title: The Newcastle-Ottawa Scale (NOS) for Assessing The Quality of Nonrandomised Studies in Meta-analyses year: 2014 ident: 2028_CR27 – volume: 13 start-page: 796 year: 2017 ident: 2028_CR51 publication-title: Med Chem doi: 10.2174/1573406413666170424155452 – volume: 173 start-page: 1111 year: 2011 ident: 2028_CR38 publication-title: Am J Epidemiol doi: 10.1093/aje/kwq510 – volume: 133 start-page: 186 year: 2019 ident: 2028_CR14 publication-title: Free Radic Biol Med doi: 10.1016/j.freeradbiomed.2018.12.015 – volume: 24 start-page: 587 year: 2021 ident: 2028_CR15 publication-title: Climacteric doi: 10.1080/13697137.2021.1948994 – ident: 2028_CR2 doi: 10.3390/cells10061381 – ident: 2028_CR7 doi: 10.3390/ijms22105196 – volume: 25 start-page: 447 year: 2015 ident: 2028_CR33 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000384 – volume: 149 start-page: 361 year: 1999 ident: 2028_CR48 publication-title: Wien Med Wochenschr – volume: 37 start-page: 162 year: 2021 ident: 2028_CR57 publication-title: Gynecol Endocrinol doi: 10.1080/09513590.2020.1855634 – volume: 362 start-page: k2644 year: 2018 ident: 2028_CR25 publication-title: BMJ doi: 10.1136/bmj.k2644 – ident: 2028_CR19 doi: 10.1016/j.ygyno.2021.01.019 – volume: 34 start-page: 499 year: 2019 ident: 2028_CR32 publication-title: Eur J Epidemiol doi: 10.1007/s10654-018-0474-9 – ident: 2028_CR11 doi: 10.1210/endrev/bnz001 – volume: 57 start-page: R19 year: 2016 ident: 2028_CR58 publication-title: J Mol Endocrinol doi: 10.1530/JME-15-0310 – volume: 37 start-page: 2580 year: 2020 ident: 2028_CR8 publication-title: Adv Ther doi: 10.1007/s12325-020-01363-5 – ident: 2028_CR43 doi: 10.3760/cma.j.issn.0529-567x.2018.12.007 – volume: 12 start-page: 28 year: 2019 ident: 2028_CR50 publication-title: J Ovarian Res doi: 10.1186/s13048-019-0503-7 – ident: 2028_CR35 doi: 10.1097/AOG.0000000000001684 – volume: 27 start-page: 1114 year: 2018 ident: 2028_CR21 publication-title: J Womens Health (Larchmt) doi: 10.1089/jwh.2017.6432 – volume: 12 start-page: 631715 year: 2021 ident: 2028_CR47 publication-title: Front Genet doi: 10.3389/fgene.2021.631715 – ident: 2028_CR4 doi: 10.1016/j.bpobgyn.2018.06.001 – ident: 2028_CR18 doi: 10.3390/ijerph13111138 – volume: 25 start-page: 968 year: 2015 ident: 2028_CR29 publication-title: Int J Gynecol Cancer doi: 10.1097/IGC.0000000000000454 – volume: 46 start-page: 156 year: 2018 ident: 2028_CR1 publication-title: Gynecol Obstet Fertil Senol doi: 10.1016/j.gofs.2018.02.017 – volume: 184 start-page: 2807 year: 2021 ident: 2028_CR3 publication-title: Cell doi: 10.1016/j.cell.2021.04.041 – volume: 96 start-page: 32 year: 2019 ident: 2028_CR10 publication-title: Vopr Kurortol Fizioter Lech Fiz Kult doi: 10.17116/kurort20199606132 – volume: 143 start-page: 2725 year: 2018 ident: 2028_CR31 publication-title: Int J Cancer doi: 10.1002/ijc.31721 – volume: 11 start-page: 3186 year: 2020 ident: 2028_CR39 publication-title: J Cancer doi: 10.7150/jca.39626 – ident: 2028_CR41 doi: 10.1371/journal.pone.0143410 – volume: 19 start-page: 72 year: 2019 ident: 2028_CR64 publication-title: BMC Womens Health doi: 10.1186/s12905-019-0770-x – volume: 16 start-page: 435 year: 2017 ident: 2028_CR53 publication-title: Technol Cancer Res Treat doi: 10.1177/1533034616666644 – volume: 4 start-page: 9 year: 2018 ident: 2028_CR5 publication-title: Nat Rev Dis Primers doi: 10.1038/s41572-018-0008-5 – volume: 26 start-page: 287 year: 2015 ident: 2028_CR60 publication-title: Cancer Causes Control doi: 10.1007/s10552-014-0510-3 – volume: 23 start-page: 584 year: 2014 ident: 2028_CR30 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-13-0996 – volume: 28 start-page: 437 year: 2017 ident: 2028_CR36 publication-title: Cancer Causes Control doi: 10.1007/s10552-017-0856-4 – volume: 3 start-page: 219 year: 2021 ident: 2028_CR46 publication-title: SciMedicine J doi: 10.28991/SciMedJ-2021-0303-3 – volume: 327 start-page: 557 year: 2003 ident: 2028_CR28 publication-title: BMJ doi: 10.1136/bmj.327.7414.557 |
SSID | ssj0017857 |
Score | 2.4796903 |
SecondaryResourceType | review_article |
Snippet | Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer.... Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and breast cancer.... Abstract Purpose Endometriosis (EMS) is confirmed pathophysiologically to be an estrogen-dependent disease, similar to endometrial hyperplasia/cancer and... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 455 |
SubjectTerms | Breast cancer Breast Neoplasms - complications Breast Neoplasms - epidemiology Cancer therapies Case studies Case-Control Studies Cohort analysis Complications and side effects Endometrial cancer Endometrial Neoplasms - epidemiology Endometriosis Endometriosis - complications Endometriosis - epidemiology Endometrium Estrogens Female Heterogeneity Hormones Humans Infertility Meta-analysis Odds Ratio Ovarian cancer Ratios Risk Risk factors Tumors Womens health |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NixUxDC-yJ0HEb0dXqSB4kGHfdDpp620Vl0XQkwt7K_3UBZ2RfW9h_3yTTt_bNwh68fAuTWaYJmmT9CW_MvbapG4VA0Vug5PUkmNaL0JovYo-yow7oKcG589f4PRMfjofzveu-qKasBkeeBbcUZLJQ-xETEHJjBYYvfYA0sXcGVe6xwX6vG0yVf8_UHpQ2xYZDUdrOm2hTmSBPzpPul64oYLW_-eevOeUlgWTex7o5B67W0NHfjx_8n12K40P2J353I3P7UQP2TfUO3c3Mue1EIunMU4_6fqsaX2x5m6MnKrK-ZRvKPjyQEZwWcieytU3deQddxx5XOsqiMkjdnby8euH07ZeptCGAfpNKxS4bGBIyhuZVYScEm522q2CA7XSHhOfAE4FL503kDGNC70i_wXBBJ_7x-xgnMb0lHE5SI_SDyKjfjsdvI44AiquMirG5IZ1W9naUJHG6cKLH7ZkHBrsrA-L-rBFH_a6YW93z_yacTb-yv2eVLbjJIzsMoCWY6vl2H9ZTsPekMItrWT8vOBqQwJOkjCx7DGGdhggdYNu2OGCE1dgWJK3JmPrDrC2GBain8HoBxr2akemJ6mqbUzTVeEhPDph8BVPZgvbTakHzHzFIBqmFra3mPOSMl58L_jgBlSPkcmz_yGk5-y2oGVDhY_6kB1sLq_SCwzDNv5lWXG_AeuSMaQ priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1Na9RAdNB6EUSsn6lVRhA8SOgmmcxHL6UWSxH0ZGFvw3zWQk3qZgv9-X1vMpttEHrYy8xLmMn7fvs-CPmsQrXwDi231jAsyVGlrZ0rrfDWswgS0GKB889f_Oyc_Vi2yxxwG3Ja5UYmJkHte4cx8gNQs8C3oE340fW_EqdG4b-reYTGY_IEW5dhSpdYTg4XDp4Xm0IZyQ8GjLlgPXINP4wq3c6UUerZ_79kvqea5mmT9_TQ6QvyPBuQ9HjE-C55FLqX5NkYfaNjUdErcgHYp2b75WlOx6Kh8_1fHKLVD5cDNZ2nmFtO-7jdgZc7JIVV2raYtL7OK4fUUIAxpcmtTF6T89Pvv0_OyjxSoXQtb9ZlLbiJirdBWMWi8DyGACJPmoUzXCykBffHcSOcZcYqHsGZc41ALcadcjY2b8hO13fhHaGsZdbHytURsFxJZ6WHFS78InLOVCxItfm22uV-4zj24konv0NyPeJDAz50woe-LcjX6ZnrsdvGg9DfEGUTJHbKTgv96kJnxtOBBct9VfvgBIsgwbyVFg5o4OzKiKogXxDhGvkZjudMLkuAS2JnLH0MBh6YSVUrC7I_gwQ-dPPtDcnoLAcGvaXagnyatvFJzG3rQn-TYLArXa3gFW9HCpuu1HDwf-u2LoiY0d7szvOd7vJP6hKuuGjAPtl7-FjvydMaGQITG-U-2VmvbsIHMLPW9mPipTvETSfz priority: 102 providerName: ProQuest |
Title | The association between endometriosis and risk of endometrial cancer and breast cancer: a meta-analysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/36401252 https://www.proquest.com/docview/2737626616 https://www.proquest.com/docview/2738192298 https://pubmed.ncbi.nlm.nih.gov/PMC9673303 https://doaj.org/article/e4eb6d12dec74f318db8b664adf19a71 |
Volume | 22 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjR1daxQxMNT2RRDx29V6RBB8kNXbbDbJCiI9aSlCixQPDl9CPmuh7rZ3V6j_3pns3l0Xi_hw95CZzSU7M5mZ3HwQ8qYOxdg7tNwqwzElp84tcy630lvPI5yAFhOcj47F4ZR_nVWzLbJqd9S_wMWtrh32k5rOz99fX_7-DAL_KQm8Eh8WeJeCecYMPnhbBDblDmgmiYJ6xDf_KkiVKn8WXLJcKMlXSTS3zjFQVKme_9-n9g21NQypvKGjDh6Q-71xSfc6bnhItkLziNzrbuZol3D0mJwCZ1CzoQrtQ7VoaHz7CxtstYuzBTWNpxh3Ttu4gcDkDtlknsAWA9qX_chHaijgmNz0ZU6ekOnB_vcvh3nfbiF3lSiXOZPCxFpUQdqaR-lFDAGOQ2XGzgg5VhZcIyeMdJYbW4sIjp4rJWo44WpnY_mUbDdtE54TyitufSwci8ABhXJWeRgR0o-jELyOGSlW71a7vhY5tsQ418knUUJ39NBAD53ooa8z8m79zEVXieOf2BMk2RoTq2ingXZ-qnuh1IEHK3zBfHCSRzjdvFUWFmhg7bWRRUbeIsE1ch8sz5k-ZQE2iVWz9B4Yf2BCFZXKyO4AE2TUDcErltErFtdgOIImAvtIZOT1GoxPYtxbE9qrhIMV61gNUzzrOGy9pVKAb8wqlhE54L3BnoeQ5uxnqiBeC1mC7fLiP373JbnLUCow8lHtku3l_Cq8AjtsaUfkjpzJEdmZ7B9_Oxml24xREjj4Ppn8-AMORzPK |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3batRAdKjbBwUR70arjqD4IKGbyWQmEURabdnadhFpoW_TudaCJnWzxfpTfqPn5LLbIPStD3mZORlmcu6TcyHkdeGTsbNouWWaY0pOERtmbWykM44HkIAGE5z3p2JyyL8cZUcr5G-fC4Nhlb1MbAS1qyzeka-DmgW-BW0iPp79irFrFP5d7VtotGSx6__8Bpet_rDzGfD7hrHtrYNPk7jrKhDbTKTzmEmhQyEyL03Bg3QieA9cn-ux1UKOcwMegBVaWsO1KUQAf8amEgW5sIU1IYV1b5BVnoIrMyKrm1vTr98W_y1knsk-NScX6zXe8mAGNIMH77EuBuqv6RLwvy64pAyHgZqXNN_2XXKnM1npRktj98iKL--T2-19H23TmB6QE6A3qpe4pl0AGPWlq35i266qPq2pLh3FaHZaheUMLG6R-GbNtMEw-Xk38p5qCjA61l3xlIfk8Fo-9yMyKqvSPyGUZ9y4kFgWgK6S3JrcwYiQbhyE4EWISNJ_W2W7CufYaOOHajydXKgWHwrwoRp8qIuIvFu8c9bW97gSehNRtoDE2tzNQDU7UR2rK8-9ES5hzlvJA8hMZ3IDG9Sw90LLJCJvEeEKJQhsz-ouEQIOibW41AaYlGCYJVkekbUBJHC-HU73JKM6yVOrJZ9E5NViGt_EaLrSV-cNDNbBYwUs8bilsMWRUgEeN8tYROSA9gZnHs6Up9-buuSFkClYRE-v3tZLcnNysL-n9namu8_ILYbMgWGV-RoZzWfn_jkYeXPzouMsSo6vm5n_AZ4iZrI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+association+between+endometriosis+and+risk+of+endometrial+cancer+and+breast+cancer%3A+a+meta-analysis&rft.jtitle=BMC+women%27s+health&rft.au=Ye%2C+Jiatian&rft.au=Peng%2C+Hongling&rft.au=Huang%2C+Xia&rft.au=Qi%2C+Xiaorong&rft.date=2022-11-18&rft.issn=1472-6874&rft.eissn=1472-6874&rft.volume=22&rft.issue=1&rft.spage=455&rft_id=info:doi/10.1186%2Fs12905-022-02028-x&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1472-6874&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1472-6874&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1472-6874&client=summon |